https://tvaxbiomedical.com/tvax-biomedical-announces-receipt-of-2-million-fda-orphan-products-grant-for-glioblastoma-study/2026-07-09T18:21:11+00:00https://tvaxbiomedical.com/tvax-biomedical-receives-fast-track-designation-from-the-fda/2026-07-09T18:30:26+00:00https://tvaxbiomedical.com/tvax-biomedical-names-wayne-carter-as-president-and-ceo/2026-07-09T18:34:15+00:00